Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...

A senior executive from GlaxoSmithKline told Chinese police the British drugmaker will reform its business in the country in the wake of a bribery scandal, as the Chinese crackdown on corruption in ...

(Bloomberg) -- Police in China have detained five current and former employees of British drugmaker AstraZeneca Plc for questioning about potential illegal activities, according to people familiar ...

In September, Chinese authorities detained five current and former employees of AstraZeneca Plc (NASDAQ:AZN) as part of a broader investigation into alleged illegal activities in the pharmaceutical ...

NEW YORK and SHANGHAI, China, Feb. 05, 2024 (GLOBE NEWSWIRE) -- Yiviva, a clinical-stage, platform biotechnology company developing systems biology medicines to treat aging-related diseases, signed a ...

AstraZeneca shares on Tuesday recorded their worst day since March 2020 after a report that dozens of the drugmaker's senior executives in China could be implicated in the largest insurance fraud case ...

AstraZeneca cooperating with Chinese authorities Update on investigation reassures market Potential fines of 1-5 times unpaid tax Company forecasts robust 2025 growth Shares up 5% at 1105 GMT Feb 6 ...

BEIJING/LONDON, Jan 29 (Reuters) - UK drugmaker AstraZeneca will invest $15 billion in China through 2030 to expand medicines manufacturing and research and development, it said on Thursday as British ...

China is AstraZeneca's second-largest market after the United States - Copyright AFP/File Jonathan NACKSTRAND China is AstraZeneca's second-largest market after the ...

An anemia drug developed under an alliance between FibroGen and AstraZeneca will continue its commercialization in China fully in the hands of the pharmaceutical giant, which is buying the China ...